People with osteoarthritis generally have less hyaluronic acid in their joints than they should. This can cause symptoms like pain, stiffness, and swelling. The idea behind viscosupplementation is that replacing this hyaluronic acid may help reduce symptoms.
Viscosupplementation is a procedure where a gel-like substance called hyaluronic acid, which is a component of synovial fluid, is injected into the joints to increase its lubricating and shock-absorbing properties.
Medicare Covered Treatment for Knee Arthritis
GenVisc is a sterile, viscoelastic non-pyrogenic solution of purified, high molecular weight sodium hyaluronate. It is administered by intra-articular injections of the knee and consists of five injections, given at a weekly interval.
It is indicated for the treatment of knee osteoarthritis (OA) in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.
Safety is our number one priority. Take a few minutes to read some important safety information regarding our viscosupplementation.
GenVisc is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics
GenVisc is contraindicated in patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of present infections or skin diseases in the area of the injection site to reduce the potential for developing septic arthritis.
Patient Success Stories
Curious to know how our patients are responding? Our patients amaze us everyday! Their life-altering results inspire our mission. We think their stories will inspire you to take action.